What is CytoBioscience?
CytoBioscience operates at the intersection of bioscience, nanoscience, microchip development, algorithms, and engineering. The company designs and manufactures sophisticated devices that enable researchers, medical institutions, and pharmaceutical companies to gain deeper insights into cellular responses to medication. With a distinguished scientific and technical team, robust collaborations with leading pharmaceutical entities, and strategic alliances with key academic and industry groups, CytoBioscience's technology is recognized for its critical applications, including exclusive use by the FDA.
How much funding has CytoBioscience raised?
CytoBioscience has raised a total of $1.4M across 1 funding round:
Other Financing Round
$1.4M
Other Financing Round (2008): $1.4M with participation from GENIUS Venture Capital
Key Investors in CytoBioscience
GENIUS Venture Capital
GENIUS Venture Capital is an investment firm that has backed CytoBioscience in its funding rounds.
What's next for CytoBioscience?
The recent major strategic investment signals a new phase of growth and development for CytoBioscience. This capital is expected to accelerate the company's product development pipeline, expand its market reach, and further solidify its position as a leader in cell-response analysis technology. Future endeavors will likely focus on scaling manufacturing capabilities and forging new partnerships to bring its advanced devices to a broader range of scientific and medical applications, driving innovation in drug discovery and personalized medicine.
See full CytoBioscience company page
